Hypertension
ACE inhibitors, ARBs, calcium channel blockers and combination therapies.
Therapeutic area
Cardiovascular health
Antihypertensives, lipid management and antithrombotic therapies for the most widely prescribed cardiovascular treatment pathways in Europe and beyond.
01 — Why it matters
Care that
cannot pause.
Cardiovascular disease remains the leading cause of mortality worldwide, and continuity of therapy is decisive for patient outcomes. VARENQOR PHARMA concentrates on molecules where uninterrupted, affordable supply directly supports long-term adherence.
Every product in this area is sourced from qualified manufacturing partners operating to European good manufacturing practice, with full analytical documentation and batch traceability.
Dosage forms
- Film-coated tablets
- Fixed-dose combinations
- Prolonged-release tablets
- Capsules
02 — Focus
Where we
concentrate.
Product selection within cardiovascular health follows clinical demand, not catalogue size.
Lipid management
Statins and complementary lipid-lowering treatments.
Antithrombotics
Platelet inhibition and anticoagulation support therapies.
Heart failure
Established supportive therapies for chronic management.
Other areas
Availability
Ask about cardiovascular health
in your market.
We confirm molecule-level availability, dossier status and registration options per country.
Start an enquiry